Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol ; volume:11 ; number:1 ; day:9 ; month:6 ; year:2010 ; pages:1-7 ; date:12.2010
Trials ; 11, Heft 1 (9.6.2010), 1-7, 12.2010
- Beteiligte Personen und Organisationen
-
Strippoli, Giovanni FM
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-11-70
- URN
-
urn:nbn:de:1111-2016050218693
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Strippoli, Giovanni FM
- SpringerLink (Online service)
Ähnliche Objekte (12)
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Dose Reduction and Dose Management in Computed Tomography – State of the Art
Evaluation of radiation dose reduction in head CT using the half-dose method
A dose of reality : the state of European cinema
Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy
Assessing the similarity of dose response and target doses in two non-overlapping subgroups
The skin dose of pelvic radiographs since 1896
Ibrutinib dose modifications in the management of CLL
Dose-Finding Designs: The Role of Convergence Properties
Dose response of ACE inhibitors: implications of the SECURE trial
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Dose Reduction and Dose Management in Computed Tomography – State of the Art
Evaluation of radiation dose reduction in head CT using the half-dose method
A dose of reality : the state of European cinema
Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy
Assessing the similarity of dose response and target doses in two non-overlapping subgroups
The skin dose of pelvic radiographs since 1896
Ibrutinib dose modifications in the management of CLL
Dose-Finding Designs: The Role of Convergence Properties
Dose response of ACE inhibitors: implications of the SECURE trial
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Dose Reduction and Dose Management in Computed Tomography – State of the Art
Evaluation of radiation dose reduction in head CT using the half-dose method
A dose of reality : the state of European cinema
Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy
Assessing the similarity of dose response and target doses in two non-overlapping subgroups
The skin dose of pelvic radiographs since 1896
Ibrutinib dose modifications in the management of CLL
Dose-Finding Designs: The Role of Convergence Properties
Dose response of ACE inhibitors: implications of the SECURE trial